Down-regulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes

被引:44
作者
Shen, WP
Li, BQ
Wetzel, MA
Rogers, TJ
Henderson, EE
Su, SB
Gong, WH
Le, YY
Sargeant, R
Dimitrov, DS
Oppenheim, JJ
Wang, JM
机构
[1] NCI, Frederick Canc Res & Dev Ctr, DBS, LMI, Frederick, MD 21702 USA
[2] NCI, SAIC Frederick, Div Basic Sci, Lab Expt & Computat Biol, Frederick, MD 21702 USA
[3] NCI, SAIC Frederick, Intramural Res Support Program, Frederick, MD 21702 USA
[4] Millennium Biotechnol, Prod Dev, Ramona, CA USA
[5] Temple Univ, Sch Med, Dept Immunol & Microbiol, Philadelphia, PA 19122 USA
关键词
D O I
10.1182/blood.V96.8.2887.h8002887_2887_2894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interactions between cell surface receptors are important regulatory elements in the complex host responses to infections. In this study, it is shown that a classic chemotactic factor, the bacterial chemotactic peptide N-formyl-methionyl-leucylphenyl-alanine (fMLF), rapidly induced a protein-kinase-C-mediated serine phosphorylation and down-regulation of the chemokine receptor CCR5, which serves as a major human immunodeficiency virus (HIV)-1 coreceptor. The fMLF binding to its receptor, formyl peptide receptor (FPR), resulted in significant attenuation of cell responses to CCR5 ligands and in inhibition of HIV-1-enveiopeglycoprotein-mediated fusion and infection of cells expressing CD4, CCR5, and FPR, The finding that the expression and function of CCR5 can be regulated by peptides that use an unrelated receptor may provide a novel approach to the design of anti-inflamatory and antiretroviral agents. (C) 2000 by The American Society of Hematology.
引用
收藏
页码:2887 / 2894
页数:8
相关论文
共 35 条
[1]   The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains [J].
Alfano, M ;
Schmidtmayerova, H ;
Amella, CA ;
Pushkarsky, T ;
Bukrinsky, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :597-605
[2]   Chemoattractant receptor cross-desensitization [J].
Ali, H ;
Richardson, RM ;
Haribabu, B ;
Snyderman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6027-6030
[3]   Mechanisms of inflammation and leukocyte activation [J].
Ali, H ;
Haribabu, B ;
Richardson, RM ;
Snyderman, R .
MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (01) :1-&
[4]   Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor [J].
Aramori, I ;
Zhang, J ;
Ferguson, SSG ;
Bieniasz, PD ;
Cullen, BR ;
Caron, MG .
EMBO JOURNAL, 1997, 16 (15) :4606-4616
[5]   HIV blocked by chemokine antagonist [J].
ArenzanaSeisdedos, F ;
Virelizier, JL ;
Rousset, D ;
ClarkLewis, I ;
Loetscher, P ;
Moser, B ;
Baggiolini, M .
NATURE, 1996, 383 (6599) :400-400
[6]  
Berger EA, 1997, AIDS, V11, pS3
[7]   MITOCHONDRIAL N-FORMYLMETHIONYL PROTEINS AS CHEMOATTRACTANTS FOR NEUTROPHILS [J].
CARP, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (01) :264-275
[8]   A MOLECULAR CLASP IN THE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 TM PROTEIN DETERMINES THE ANTI-HIV ACTIVITY OF GP41 DERIVATIVES - IMPLICATION FOR VIRAL FUSION [J].
CHEN, CH ;
MATTHEWS, TJ ;
MCDANAL, CB ;
BOLOGNESI, DP ;
GREENBERG, ML .
JOURNAL OF VIROLOGY, 1995, 69 (06) :3771-3777
[9]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[10]   Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene [J].
Dean, M ;
Carrington, M ;
Winkler, C ;
Huttley, GA ;
Smith, MW ;
Allikmets, R ;
Goedert, JJ ;
Buchbinder, SP ;
Vittinghoff, E ;
Gomperts, E ;
Donfield, S ;
Vlahov, D ;
Kaslow, R ;
Saah, A ;
Rinaldo, C ;
Detels, R ;
OBrien, SJ .
SCIENCE, 1996, 273 (5283) :1856-1862